The pahtway p174 has 60 genes in the original annotation. Currently, there are 47 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
| Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
| 1147 | CHUK | IKBKA | IKK-alpha | IKK1 | IKKA | NFKBIKA | TCF16 | conserved helix-loop-helix ubiquitous kinase | | | 10q24-q25 |
| 6934 | TCF7L2 | TCF-4 | TCF4 | transcription factor 7 like 2 | | | 10q25.3 |
| 6688 | SPI1 | OF | PU.1 | SFPI1 | SPI-1 | SPI-A | Spi-1 proto-oncogene | | | 11p11.2 |
| 3265 | HRAS | C-BAS/HAS | C-H-RAS | C-HA-RAS1 | CTLO | H-RASIDX | HAMSV | HRAS1 | RASH1 | p21ras | Harvey rat sarcoma viral oncogene homolog | | | 11p15.5 |
| 5970 | RELA | NFKB3 | p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | | | 11q13 |
| 595 | CCND1 | BCL1 | D11S287E | PRAD1 | U21B31 | cyclin D1 | | | 11q13 |
| 6199 | RPS6KB2 | KLS | P70-beta | P70-beta-1 | P70-beta-2 | S6K-beta2 | S6K2 | SRK | STK14B | p70(S6K)-beta | p70S6Kb | ribosomal protein S6 kinase B2 | | | 11q13.2 |
| 7704 | ZBTB16 | PLZF | ZNF145 | zinc finger and BTB domain containing 16 | | | 11q23.1 |
| 3845 | KRAS | C-K-RAS | CFC2 | K-RAS2A | K-RAS2B | K-RAS4A | K-RAS4B | KI-RAS | KRAS1 | KRAS2 | NS | NS3 | RALD | RASK2 | Kirsten rat sarcoma viral oncogene homolog | | | 12p12.1 |
| 6655 | SOS2 | NS9 | SOS Ras/Rho guanine nucleotide exchange factor 2 | | | 14q21 |
| 207 | AKT1 | AKT | CWS6 | PKB | PKB-ALPHA | PRKBA | RAC | RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 | | | 14q32.32 |
| 5371 | PML | MYL | PP8675 | RNF71 | TRIM19 | promyelocytic leukemia | | | 15q22 |
| 5604 | MAP2K1 | CFC3 | MAPKK1 | MEK1 | MKK1 | PRKMK1 | mitogen-activated protein kinase kinase 1 | | | 15q22.1-q22.33 |
| 5595 | MAPK3 | ERK-1 | ERK1 | ERT2 | HS44KDAP | HUMKER1A | P44ERK1 | P44MAPK | PRKM3 | p44-ERK1 | p44-MAPK | mitogen-activated protein kinase 3 | | | 16p11.2 |
| 23533 | PIK3R5 | F730038I15Rik | FOAP-2 | P101-PI3K | p101 | phosphoinositide-3-kinase regulatory subunit 5 | | | 17p13.1 |
| 6776 | STAT5A | MGF | STAT5 | signal transducer and activator of transcription 5A | | | 17q11.2 |
| 5914 | RARA | NR1B1 | RAR | retinoic acid receptor alpha | | | 17q21 |
| 3728 | JUP | ARVD12 | CTNNG | DP3 | DPIII | PDGB | PKGB | junction plakoglobin | | | 17q21 |
| 6774 | STAT3 | ADMIO | APRF | HIES | signal transducer and activator of transcription 3 (acute-phase response factor) | | | 17q21.31 |
| 2885 | GRB2 | ASH | EGFRBP-GRB2 | Grb3-3 | MST084 | MSTP084 | NCKAP2 | growth factor receptor bound protein 2 | | | 17q24-q25 |
| 5605 | MAP2K2 | CFC4 | MAPKK2 | MEK2 | MKK2 | PRKMK2 | mitogen-activated protein kinase kinase 2 | | | 19p13.3 |
| 1050 | CEBPA | C/EBP-alpha | CEBP | CCAAT/enhancer binding protein alpha | | | 19q13.1 |
| 208 | AKT2 | HIHGHH | PKBB | PKBBETA | PRKBB | RAC-BETA | v-akt murine thymoma viral oncogene homolog 2 | | | 19q13.1-q13.2 |
| 5296 | PIK3R2 | MPPH | MPPH1 | P85B | p85 | p85-BETA | phosphoinositide-3-kinase regulatory subunit 2 | | | 19q13.2-q13.4 |
| 4893 | NRAS | ALPS4 | CMNS | N-ras | NCMS | NRAS1 | NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog | | | 1p13.2 |
| 8503 | PIK3R3 | p55 | p55-GAMMA | p55PIK | phosphoinositide-3-kinase regulatory subunit 3 | | | 1p34.1 |
| 5293 | PIK3CD | APDS | IMD14 | P110DELTA | PI3K | p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | | | 1p36.2 |
| 2475 | MTOR | FRAP | FRAP1 | FRAP2 | RAFT1 | RAPT1 | SKS | mechanistic target of rapamycin | | | 1p36.2 |
| 10000 | AKT3 | MPPH | MPPH2 | PKB-GAMMA | PKBG | PRKBG | RAC-PK-gamma | RAC-gamma | STK-2 | v-akt murine thymoma viral oncogene homolog 3 | | | 1q44 |
| 861 | RUNX1 | AML1 | AML1-EVI-1 | AMLCR1 | CBF2alpha | CBFA2 | EVI-1 | PEBP2aB | PEBP2alpha | runt related transcription factor 1 | | | 21q22.3 |
| 5594 | MAPK1 | ERK | ERK-2 | ERK2 | ERT1 | MAPK2 | P42MAPK | PRKM1 | PRKM2 | p38 | p40 | p41 | p41mapk | p42-MAPK | mitogen-activated protein kinase 1 | | | 22q11.21 |
| 83439 | TCF7L1 | TCF-3 | TCF3 | transcription factor 7 like 1 | | | 2p11.2 |
| 5894 | RAF1 | CMD1NN | CRAF | NS5 | Raf-1 | c-Raf | Raf-1 proto-oncogene, serine/threonine kinase | | | 3p25 |
| 5291 | PIK3CB | P110BETA | PI3K | PI3KBETA | PIK3C1 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | | | 3q22.3 |
| 5290 | PIK3CA | CLOVE | CWS5 | MCAP | MCM | MCMTC | PI3K | p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | | | 3q26.3 |
| 3815 | KIT | C-Kit | CD117 | PBT | SCFR | KIT proto-oncogene receptor tyrosine kinase | | | 4q12 |
| 4790 | NFKB1 | CVID12 | EBP-1 | KBF1 | NF-kB1 | NF-kappa-B | NF-kappaB | NFKB-p105 | NFKB-p50 | NFkappaB | p105 | p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | | | 4q24 |
| 51176 | LEF1 | LEF-1 | TCF10 | TCF1ALPHA | TCF7L3 | lymphoid enhancer binding factor 1 | | | 4q25 |
| 5295 | PIK3R1 | AGM7 | GRB1 | IMD36 | p85 | p85-ALPHA | phosphoinositide-3-kinase regulatory subunit 1 | | | 5q13.1 |
| 6932 | TCF7 | TCF-1 | transcription factor 7 (T-cell specific, HMG-box) | | | 5q31.1 |
| 5467 | PPARD | FAAR | NR1C2 | NUC1 | NUCI | NUCII | PPARB | peroxisome proliferator activated receptor delta | | | 6p21.2 |
| 5292 | PIM1 | PIM | Pim-1 proto-oncogene, serine/threonine kinase | | | 6p21.2 |
| 673 | BRAF | B-RAF1 | BRAF1 | NS7 | RAFB1 | B-Raf proto-oncogene, serine/threonine kinase | | | 7q34 |
| 3551 | IKBKB | IKK-beta | IKK2 | IKKB | IMD15 | NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | | | 8p11.2 |
| 1978 | EIF4EBP1 | 4E-BP1 | 4EBP1 | BP-1 | PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 | | | 8p12 |
| 862 | RUNX1T1 | AML1-MTG8 | AML1T1 | CBFA2T1 | CDR | ETO | MTG8 | ZMYND2 | runt related transcription factor 1; translocated to, 1 (cyclin D related) | | | 8q22 |
| 4609 | MYC | MRTL | MYCC | bHLHe39 | c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | | | 8q24.21 |
